|Home||» Products||» Muscle Relaxtant & Antispasmodic||» Leflunomide|
- Minimum Order Quantity
LEFUMIDE is indicated in adults for the treatment of active RA and active psoriatic arthritis:
To reduce signs and symptoms.
To inhibit structural damage as evidenced by X-ray erosions and joint space narrowing.
To improve physical function.
Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs) and/or low-dose corticosteroids may be continued during treatment with leflunomide. The combined use of leflunomide with antimalarials, intramuscular or oral gold, D penicillamine, azathioprine or methotrexate has not been adequately studied.
- Main Export Market(s)
- Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia